Back to Search
CASTRO BONNY, MD
MD
Family Medicine Physician
NPI: 1760941751IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
ME150937(FL)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.
PMID 19609503·Diabetologia·2009
7-preclinical
c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
PMID 19135136·Neuroscience·2009
7-preclinical
Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases.
PMID 18263705·FASEB J·2008
8-other
The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator.
PMID 18728363·Cerebrovasc Dis·2008
7-preclinical
Modulation of the c-Jun N-terminal kinase activity in the embryonic heart in response to anoxia-reoxygenation: involvement of the Ca2+ and mitoKATP channels.
PMID 18418700·Mol Cell Biochem·2008
7-preclinical
D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats.
PMID 18262367·Neuroscience·2008
7-preclinical
Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.
PMID 17900813·Neuroscience·2007
7-preclinical
A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.
PMID 17158645·Am J Physiol Heart Circ Physiol·2007
7-preclinical
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase.
PMID 17475657·J Virol·2007
7-preclinical
Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons.
PMID 16794604·Cell Death Differ·2007
7-preclinical
The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis.
PMID 17558486·Diabetologia·2007
7-preclinical
The epidemiology and virology of hepatitis C virus genotype 5 in central France.
PMID 17900267·Aliment Pharmacol Ther·2007
4-observational
Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity.
PMID 17098385·Hear Res·2007
7-preclinical
Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals.
PMID 17132689·Mol Pharmacol·2007
7-preclinical
Cell-permeable peptides induce dose- and length-dependent cytotoxic effects.
PMID 17626783·Biochim Biophys Acta·2007
7-preclinical
Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
PMID 17109680·J Viral Hepat·2006
4-observational
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
PMID 16907892·Aliment Pharmacol Ther·2006
4-observational
Blocking stress signaling pathways with cell permeable peptides.
PMID 17089885·Adv Exp Med Biol·2006
6-review
Homogeneous and nonradioactive high-throughput screening platform for the characterization of kinase inhibitors in cell lysates.
PMID 17092917·J Biomol Screen·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1611 NW 12TH AVE, LOCATOR CODE R-700
MIAMI, FL 33136 - Phone
- (305) 243-2848
Quick Facts
- NPI
- 1760941751
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile